Home›Companies›Healthcare›Sora Neuroscience

Sora Neuroscience, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 20, 2024·Suggest an edit

About Sora Neuroscience

Sora Neuroscience is a private company based in Minneapolis, Minnesota, incorporated in 2020 in Delaware. It has reported $3,407,500 raised in two offerings on Form D since September 2021. Its chief executive is Stephen Schaefer.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 16, 2023Oct 31, 2023amended Nov 20, 2024$1,427,500of $2.0M target20$71,375EquityRule 506(b)Form D/A ↗1 earlier filing
Aug 23, 2021Sep 9, 2021$1,980,000of $2.5M target21$94,286EquityRule 506(b)Form D ↗
Total, two offerings$3,407,500

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Sora Neuroscience's Form D filed Nov 20, 2024.

AS
Ann Senn
Director
SS
Stephen Schaefer
Chief Executive Officer and director
TB
Tara Butler
Director
DM
EL

Sources

  1. SECSora Neuroscience, Inc. Form D, filed Oct 31, 2023
  2. SECSora Neuroscience, Inc. filing history